# Zonisamide for the Treatment of Obstructive Sleep Apnea in Overweight/Obese Patients

> **NCT01765608** · PHASE2 · COMPLETED · sponsor: **Göteborg University** · enrollment: 50 (actual)

## Conditions studied

- Sleep Apnea
- Obstructive Sleep Apnea
- Obesity

## Interventions

- **DRUG:** Zonisamide
- **DRUG:** Placebo
- **DEVICE:** nCPAP

## Key facts

- **NCT ID:** NCT01765608
- **Lead sponsor:** Göteborg University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01765608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01765608, "Zonisamide for the Treatment of Obstructive Sleep Apnea in Overweight/Obese Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01765608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*